(0)

Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Washington Marriott Wardman Park

18 feb 2015 8:00 a.m. - 19 feb 2015 5:00 p.m.

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Marketing Pharmaceuticals 2015: Drug/Device Marketing in an Evolving Environment

Volver a Agendas

Session 1: Compliance Update

Session Chair(s)

John T. Murray

John T. Murray

President

Grayscale Compliance LLC, United States

With the maturity of Corporate Integrity Agreements (CIAs) and compliance programs, many companies have ended or are near completion. The panel will discuss the key issues of managing completion of CIAs and what components are critical to remain after the CIA is complete. The panel will also discuss current trends in marketing compliance that are expected to impact drug promotion in the coming years.

Speaker(s)

Kathleen Meriwether

Speaker

Kathleen Meriwether

Ernst and Young, United States

Principal, Assurance Services - Fraud Investigation and Dispute Services

Jeffrey E. Fleming

Speaker

Jeffrey E. Fleming

AstraZeneca, United States

VP Compliance North America

Joy Liu, JD

Speaker

Joy Liu, JD

Ropes and Gray, United States

Partner

Wendy C. Goldstein

Speaker

Wendy C. Goldstein

Cooley, LLP, United States

Partner

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.